The Series B syndicate includes both new and existing investors, including ARCH Venture Partners, the Flippen Group, GPG Ventures, 4D Capital and others.
Recuro will use the proceeds to advance and scale its Digital Medical Home, which includes diagnostic-enabled Virtual Primary Care and Virtual Behavioural Health Solutions that are tailored to fit the healthcare needs of any population.
The Digital Medical Home care model integrates advanced science, data, at-home diagnostics and targeted genomics to better inform integrated care.
Recuro Health founder and CEO, Michael Gorton, said:
“The continued support of our investors is a clear sign of their confidence in our mission.
“We have an extraordinary team at Recuro dedicated to evolving healthcare to be more proactive and personal, resulting in improved outcomes, better patient engagement and lower costs.
“In this next phase of our Company growth and expansion, we are committed to building upon the success of our Digital Medical Home and continuing to advance the next generation of digital care services.”
Recuro’s Digital Medical Home enables connectivity to virtual care, including primary and urgent care, behavioural health, at-home lab testing, genomics testing, as well as a suite of supplemental offering spanning pharmacy, care management and care navigation in one platform
Robert Nelsen, co-founder and managing director, ARCH Venture Partners, added:
“Recuro is proving to be the best of breed in the intersection of science, diagnostics and digital health.
“This nimble organisation has the ability to quickly respond to market changes, scale its tech-enabled services and close gaps in care that improve population health.
“We see significant opportunities for exceptional growth and continued success.”
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
Urgent work needed to tackle ‘substantial’ digital health inequality
eSight: “The technology has the potential to change someone’s life”
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
- News3 weeks ago
Why a leading healthcare CEO sees recombinant DNA as a metaphor for developing breakthrough technologies
- AI6 days ago
AI model predicts breast cancer risk without racial bias
- Medtech4 weeks ago
Surtex Instruments to unveil game-changing Infinex microsurgery instruments at MEDICA
- AI2 weeks ago
Humans make better cancer treatment decisions than AI, study finds